MedPath
TGA Approval

NEXTSTELLIS estetrol (as monohydrate) 14.2 mg / drospirenone 3 mg tablet blister pack (341876)

341876

NEXTSTELLIS estetrol (as monohydrate) 14.2 mg / drospirenone 3 mg tablet blister pack

Mayne Pharma International Pty Ltd

November 26, 2021

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/aa105f29283f43a714dee43a908dda8c.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/4dbf99641e031393e5f3c0d9c1dfe678.pdf

Active Ingredients

drospirenone

estetrol monohydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NEXTSTELLIS estetrol (as monohydrate) 14.2 mg / drospirenone 3 mg tablet blister pack (341876) - TGA 批准文号 | MedPath